JACC:女性冠心病患者的冠脉功能不全与不良预后相关

2019-02-16 不详 网络

目前,近一半疑似有心梗的女性并无冠脉梗阻性疾病(CAD),反倒是冠脉的反应性异常(CR)比较常见。本研究的目的旨在评估和比较有或无CAD女性的CR发生率和远期不良心血管结局(MACE)。本研究纳入了224名有症状的冠心病女性患者,并对其进行了CR检测,经过平均9.7年时间的随访,共有129例不良心血管事件发生,低冠状动脉血流储备是MACE增高的预测因子([HR]: 1.06; 95% [CI]:

目前,近一半疑似有心梗的女性并无冠脉梗阻性疾病(CAD),反倒是冠脉的反应性异常(CR)比较常见。本研究的目的旨在评估和比较有或无CAD女性的CR发生率和远期不良血管结局(MACE)。

本研究纳入了224名有症状的冠心病女性患者,并对其进行了CR检测,经过平均9.7年时间的随访,共有129例不良血管事件发生,低冠状动脉血流储备是MACE增高的预测因子([HR]: 1.06; 95% [CI]: 1.01 - 1.12; p = 0.021),低冠脉血流可增加患者死亡风险(HR: 1.12; 95% CI: 1.01 - 1.24; p = 0.038)和MACE风险(HR: 1.11; 95% CI: 1.03 - 1.20; p = 0.006)。另外,心外膜冠脉硝酸甘油的扩张与临床结局不呈相关性。

研究结果显示,在有临床症状的冠心病女性中,微血管的功能损伤与主要不良心血管结局相关。

原始出处:

本文系梅斯医学(MedSci)原创编译整理,转载需授权

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1854313, encodeId=0c60185431378, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Sun Sep 29 11:42:00 CST 2019, time=2019-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=361306, encodeId=514d361306a5, content=女性冠心病患者的治疗。, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sat Feb 23 06:51:41 CST 2019, time=2019-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1326129, encodeId=19351326129ce, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Mon Feb 18 12:42:00 CST 2019, time=2019-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1336379, encodeId=291913363e9c4, content=<a href='/topic/show?id=071820530c5' target=_blank style='color:#2F92EE;'>#不良预后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20530, encryptionId=071820530c5, topicName=不良预后)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c97a2500111, createdName=thinkibmz_44722594, createdTime=Mon Feb 18 12:42:00 CST 2019, time=2019-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1447744, encodeId=d8d1144e74447, content=<a href='/topic/show?id=523a3082670' target=_blank style='color:#2F92EE;'>#冠心病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30826, encryptionId=523a3082670, topicName=冠心病患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99445365987, createdName=liubm557, createdTime=Mon Feb 18 12:42:00 CST 2019, time=2019-02-18, status=1, ipAttribution=)]
    2019-09-29 hbwxf
  2. [GetPortalCommentsPageByObjectIdResponse(id=1854313, encodeId=0c60185431378, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Sun Sep 29 11:42:00 CST 2019, time=2019-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=361306, encodeId=514d361306a5, content=女性冠心病患者的治疗。, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sat Feb 23 06:51:41 CST 2019, time=2019-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1326129, encodeId=19351326129ce, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Mon Feb 18 12:42:00 CST 2019, time=2019-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1336379, encodeId=291913363e9c4, content=<a href='/topic/show?id=071820530c5' target=_blank style='color:#2F92EE;'>#不良预后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20530, encryptionId=071820530c5, topicName=不良预后)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c97a2500111, createdName=thinkibmz_44722594, createdTime=Mon Feb 18 12:42:00 CST 2019, time=2019-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1447744, encodeId=d8d1144e74447, content=<a href='/topic/show?id=523a3082670' target=_blank style='color:#2F92EE;'>#冠心病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30826, encryptionId=523a3082670, topicName=冠心病患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99445365987, createdName=liubm557, createdTime=Mon Feb 18 12:42:00 CST 2019, time=2019-02-18, status=1, ipAttribution=)]
    2019-02-23 jyzxjiangqin

    女性冠心病患者的治疗。

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1854313, encodeId=0c60185431378, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Sun Sep 29 11:42:00 CST 2019, time=2019-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=361306, encodeId=514d361306a5, content=女性冠心病患者的治疗。, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sat Feb 23 06:51:41 CST 2019, time=2019-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1326129, encodeId=19351326129ce, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Mon Feb 18 12:42:00 CST 2019, time=2019-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1336379, encodeId=291913363e9c4, content=<a href='/topic/show?id=071820530c5' target=_blank style='color:#2F92EE;'>#不良预后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20530, encryptionId=071820530c5, topicName=不良预后)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c97a2500111, createdName=thinkibmz_44722594, createdTime=Mon Feb 18 12:42:00 CST 2019, time=2019-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1447744, encodeId=d8d1144e74447, content=<a href='/topic/show?id=523a3082670' target=_blank style='color:#2F92EE;'>#冠心病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30826, encryptionId=523a3082670, topicName=冠心病患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99445365987, createdName=liubm557, createdTime=Mon Feb 18 12:42:00 CST 2019, time=2019-02-18, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1854313, encodeId=0c60185431378, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Sun Sep 29 11:42:00 CST 2019, time=2019-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=361306, encodeId=514d361306a5, content=女性冠心病患者的治疗。, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sat Feb 23 06:51:41 CST 2019, time=2019-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1326129, encodeId=19351326129ce, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Mon Feb 18 12:42:00 CST 2019, time=2019-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1336379, encodeId=291913363e9c4, content=<a href='/topic/show?id=071820530c5' target=_blank style='color:#2F92EE;'>#不良预后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20530, encryptionId=071820530c5, topicName=不良预后)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c97a2500111, createdName=thinkibmz_44722594, createdTime=Mon Feb 18 12:42:00 CST 2019, time=2019-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1447744, encodeId=d8d1144e74447, content=<a href='/topic/show?id=523a3082670' target=_blank style='color:#2F92EE;'>#冠心病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30826, encryptionId=523a3082670, topicName=冠心病患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99445365987, createdName=liubm557, createdTime=Mon Feb 18 12:42:00 CST 2019, time=2019-02-18, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1854313, encodeId=0c60185431378, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Sun Sep 29 11:42:00 CST 2019, time=2019-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=361306, encodeId=514d361306a5, content=女性冠心病患者的治疗。, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sat Feb 23 06:51:41 CST 2019, time=2019-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1326129, encodeId=19351326129ce, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Mon Feb 18 12:42:00 CST 2019, time=2019-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1336379, encodeId=291913363e9c4, content=<a href='/topic/show?id=071820530c5' target=_blank style='color:#2F92EE;'>#不良预后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20530, encryptionId=071820530c5, topicName=不良预后)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c97a2500111, createdName=thinkibmz_44722594, createdTime=Mon Feb 18 12:42:00 CST 2019, time=2019-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1447744, encodeId=d8d1144e74447, content=<a href='/topic/show?id=523a3082670' target=_blank style='color:#2F92EE;'>#冠心病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30826, encryptionId=523a3082670, topicName=冠心病患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99445365987, createdName=liubm557, createdTime=Mon Feb 18 12:42:00 CST 2019, time=2019-02-18, status=1, ipAttribution=)]

相关资讯

JACC:心肌淀粉样变性患者直流电复律的预后研究

心律失常、传导异常和心脏内栓塞是心肌淀粉样变性(CA)的常见并发症,对伴心房心律失常CA患者进行直流电复律(DCCV)的预后尚不清楚。本研究的目的旨在评估CA患者接受DCCV的预后。本研究纳入了58例CA患者(平均年龄69 ± 9 岁,男性占81%),与对照患者相比,CA患者电复律取消的概率更大(28% vs. 7%; p < 0.001),主要由于心脏内血栓形成(81% vs. 25%;

JACC:冠心病伴糖尿病患者冠脉搭桥远期死亡率低于介入治疗

FREEDOM临床研究结果显示对于伴有多支冠脉病变(MVD)的糖尿病患者, 随访3.8年后,冠脉搭桥手术(CABG)在减少主要心脑血管不良事件方面要优于药物洗脱支架的介入治疗(PCI-DES)。本研究的目的旨在比较FREEDOM临床研究中伴MVD糖尿病患者的远期预后。FREEDOM临床研究将1900例患者随机分成PCI-DES组和CABG组,研究结束后又邀请参与者进行随访研究。最终,共有来自25个

Nature:睡眠不足或质量差如何影响心血管健康?

本周《自然》在线发表的一篇论文Sleep modulates haematopoiesis and protects against atherosclerosis描述了睡眠影响小鼠动脉粥样硬化(动脉内斑块积聚)风险的机制。尽管这些发现有待在人类中复制,但它们表明充足的睡眠和心血管健康之间存在因果关系。

JACC:体外膜肺氧合过程中减左室负荷可降低患者死亡率

体外膜式氧合支持治疗(VA-ECMO)常被用于难治性心源性休克患者的体外循环支持治疗中,该方法的一个常见缺点是左心室后负荷增加。本次荟萃分析的目的旨在评估心源性休克患者接受VA-ECMO治疗时左室减负荷策略的安全性和有效性。本研究的主要终点事件是全因死亡率,次要终点事件包括肢体缺血、出血、肾移植、多器官功能损害、卒中和溶血。在所有2221篇文献中,有17个观察性研究符合入选标准,最终共纳入3997

盘点:JACC二月第二期研究一览

1.远期经导管主动脉瓣功能良好DOI: 10.1016/j.jacc.2018.10.078http://www.onlinejacc.org/content/73/5 目前,关于经导管主动脉瓣置换术(TAVR)后瓣膜的远期耐用性尚不清楚。本研究的目的旨在评估TAVR术后5-10年结构瓣膜退化(SVD)的发病率。本研究纳入了英国TAVI 数据库中2007-2011年接受TAVR治疗的

JACC:降主动脉瘤的治疗——开放手术vs血管内修复术

对于降主动脉瘤的治疗,近期有研究显示开放手术治疗在早期(2年内)优于胸主动脉内修复术(TEVAR)。本研究的目的旨在比较和评估开放手术修复和TEVAR对完整降主动脉瘤的疗效。本研究纳入了1999-2010年1235例接受开放手术修复和2470例相匹配的接受TEVAR的完整降主动脉瘤患者,随访9年后结果显示开放手术修复的围手术死亡风险更高,限制平均生存时间差在TEVAR组中更佳。另外,再治疗的风险在